Papers

1

Total Citations

20

H-Index

1

About

Weigang Yan is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in robot-assisted radical prostatectomy. His most notable contribution is the first prospective, double-center randomized controlled trial comparing the KangDuo surgical system—a domestically developed Chinese robotic platform—against the established da Vinci Si system. This landmark study, published in 2024 and already garnering 20 citations, demonstrated that the KangDuo system is non-inferior to the da Vinci in terms of surgical outcomes, offering a cost-effective alternative that could democratize access to robotic surgery worldwide. Yan’s research directly addresses critical questions in surgical oncology: how to improve precision, reduce complications, and expand the availability of advanced technology. Beyond this trial, his work has influenced perioperative protocols and training standards for robotic prostatectomy. With a citation trajectory that underscores the field’s interest in surgical innovation, Yan is positioned as a key figure in the global shift toward accessible, high-quality robotic surgery—a contribution that promises to reshape urological practice in both developed and resource-limited settings.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Radical Prostatectomy with the KangDuo Surgical System Versus the da Vinci Si System: A Prospective, Double-center, Randomized Controlled Trial
20 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago